Professor Judy Coulson PhD

Research Grants

Developing a chick embryo model to aid in development of personalised therapies for malignant pleural mesothelioma

NATIONAL CENTRE FOR THE REP, REF AND RED OF ANIMALS USED IN RESEARCH (NC3RS)

November 2019 - January 2023

Integrative analysis of BAP1-dependencies to identify novel therapeutic targets for uveal melanoma: learning lessons from the lung

FIGHT FOR SIGHT (UK)

October 2019 - December 2022

Translating discovery science: DUBs that regulate centrosome clustering, an Achilles' heel of cancer

BREAST CANCER NOW (UK)

October 2019 - September 2023

The Role of Reversible Ubiquitination in Virus Infection

ROYAL EMBASSY OF SAUDI ARABIA CULTURAL BUREAU IN LONDON (UK)

October 2016 - September 2020

Translating BAP1 dependencies for precision therapy of mesothelioma

BRITISH LUNG FOUNDATION (UK)

March 2017 - March 2021

Wellcome Trust Four-Year PhD Studentship with the Cellular and Molecular Physiology PhD Programme

WELLCOME TRUST (UK)

October 2015 - September 2019

Mechanistic study of the reduction of RBM4 in cancer and its role in regulating the oncogenic SRSF1

DEPARTMENT FOR BUSINESS, INNOVATION AND SKILLS (UK)

March 2015 - March 2018

Investigating in vivo resistance mechanisms to MEK inhibitors in uveal melanoma to enable novel combinatorial therapies.

NORTH WEST CANCER RESEARCH INCORPORATING CLATTERBRIDGE CANCER RESEARCH - NWCR (UK)

March 2016 - May 2019

S18-phosphorylation controls catalytic activity of the cancer-associated deubiquitylase USP7: defining the implications for cancer biology and USP7 inhibitor therapy

NORTH WEST CANCER RESEARCH INCORPORATING CLATTERBRIDGE CANCER RESEARCH - NWCR (UK)

October 2016 - December 2019

Wellcome trust four-year PhD studentship with the cellular and molecular physiology PhD programme

WELLCOME TRUST (UK)

October 2012 - September 2016

Wellcome Trust Four-Year PhD Studentship with the Cellular and Molecular Physiology Programme

WELLCOME TRUST (UK)

October 2011 - March 2016

Regulation and substrate-specificity for isoforms of the debiquitinase USP15 during the cell cycle

NORTH WEST CANCER RESEARCH FUND

February 2013 - February 2015

Isogenic cell lines for targeted therapy discovery and development in BAP1-deficient mesothelioma

BRITISH LUNG FOUNDATION (UK)

October 2012 - January 2016

Targeting an Achilles’ heel of cancer: Deubiquitylases as novel targets for centrosome de-clustering and cancer-cell specific cell death

NORTH WEST CANCER RESEARCH INCORPORATING CLATTERBRIDGE CANCER RESEARCH - NWCR (UK)

March 2015 - February 2018

Wellcome Trust four year PhD studentship with the Cellular and Molecular Physiology Programme

WELLCOME TRUST (UK)

October 2013 - September 2017

Novel isogenic models of BAP1-deficient uveal melanoma for drug discovery

FIGHT FOR SIGHT (UK)

October 2014 - September 2018